Conmed (CNMD) EBIT Growth (1y) (2011 - 2026)
Conmed (CNMD) EBIT Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.16 Bn | 176.87 Bn | 6.27 Bn | -20.56% |
| 2 | Stryker | 128.86 Bn | 125.98 Bn | 3.81 Bn | 11.83% |
| 3 | Medtronic | 108.89 Bn | 99.67 Bn | 6.41 Bn | 30.43% |
| 4 | Boston Scientific | 68.54 Bn | 67.08 Bn | 3.61 Bn | 19.54% |
| 5 | Edwards Lifesciences | 47.44 Bn | 43.76 Bn | 1.29 Bn | 20.97% |
| 6 | GE HealthCare Technologies | 28.45 Bn | 26.16 Bn | 1.98 Bn | -18.12% |
| 7 | Dexcom | 28.36 Bn | 27.24 Bn | 750.30 Mn | 90.95% |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 25.54 Bn | 22.42 Bn | 2.07 Bn | 74.18% |
| 10 | Conmed | 1.34 Bn | 1.30 Bn | 183.45 Mn | 59.26% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 59.26% |
| Dec 31, 2025 | -30.24% |
| Sep 30, 2025 | -81.92% |
| Jun 30, 2025 | -18.99% |
| Mar 31, 2025 | -54.42% |
| Dec 31, 2024 | 4.61% |
| Sep 30, 2024 | 116.85% |
| Jun 30, 2024 | 71.81% |
| Mar 31, 2024 | 175.71% |
| Dec 31, 2023 | 4,683.29% |
| Sep 30, 2023 | 24.96% |
| Jun 30, 2023 | 12.10% |
| Mar 31, 2023 | -43.42% |
| Dec 31, 2022 | -102.94% |
| Sep 30, 2022 | -9.22% |
| Jun 30, 2022 | -4.86% |
| Mar 31, 2022 | 11.76% |
| Dec 31, 2021 | 50.67% |
| Sep 30, 2021 | -9.09% |
| Jun 30, 2021 | 221.00% |